Company / FCF Margin
KYNTRA BIO, INC. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-466.8%
FY2025
5-year range
-678.5% / 44.0%
FY2021-FY2025
Trend
+31.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin returned to growth in FY2025 after 2 years of decline, reaching -466.8%.
Based on SEC 10-K filings.
-466.8% in FY2025 with a 5-year CAGR of -427.3%.
Declined from -37.1% to -466.8% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -510.8pp
- 5-Year Change
- -427.3pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 31.2% year-over-year.
- Peak fcf margin was recorded in FY2022.
- Lowest fcf margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -466.8% | +31.2% |
| FY2024 | -678.5% | -1726.3% |
| FY2023 | -37.1% | -184.4% |
| FY2022 | 44.0% | +233.7% |
| FY2021 | -32.9% | +16.7% |
| FY2020 | -39.5% | +31.0% |
| FY2019 | -57.3% | -1889.4% |
| FY2018 | 3.2% | +128.2% |
| FY2017 | -11.4% | -209.3% |
| FY2016 | 10.4% | -44.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026